×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CLSD – clearside biomedical, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CLSD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/1
07:05 am
clsd
Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
Low
Report
Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
3/31
08:16 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/29
09:02 am
clsd
Clearside Biomedical Full Year 2024 Earnings: In Line With Expectations [Yahoo! Finance]
Medium
Report
Clearside Biomedical Full Year 2024 Earnings: In Line With Expectations [Yahoo! Finance]
3/28
08:50 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
3/28
08:20 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its price target lowered by analysts at Needham & Company LLC from $6.00 to $4.00. They now have a "buy" rating on the stock.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its price target lowered by analysts at Needham & Company LLC from $6.00 to $4.00. They now have a "buy" rating on the stock.
3/27
04:12 pm
clsd
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/27
04:05 pm
clsd
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Medium
Report
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
3/24
07:05 am
clsd
Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
Medium
Report
Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
Date
Time
Symbol
Company Name
Action
%Chg
3/27/2025
04:05 pm
clsd
clearside biomedical, inc.
BEAT
Report
-7.8%
clearside biomedical, inc.
11/12/2024
04:05 pm
clsd
clearside biomedical, inc.
BEAT
Report
-2.7%
clearside biomedical, inc.
8/12/2024
04:05 pm
clsd
clearside biomedical, inc.
BEAT
Report
-0.5%
clearside biomedical, inc.
5/9/2024
04:05 pm
clsd
clearside biomedical, inc.
MISS
Report
-7.4%
clearside biomedical, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
06:11 am
clsd
Form SCHEDULE 13G Clearside Biomedical, Filed by: Wiles Stephen Boyd
Low
Report
Form SCHEDULE 13G Clearside Biomedical, Filed by: Wiles Stephen Boyd
3/27
04:30 pm
clsd
Form 10-K Clearside Biomedical, For: Dec 31
Medium
Report
Form 10-K Clearside Biomedical, For: Dec 31
3/27
04:15 pm
clsd
Form 8-K Clearside Biomedical, For: Mar 27
Medium
Report
Form 8-K Clearside Biomedical, For: Mar 27
3/4
05:21 pm
clsd
Form SCHEDULE 13G/A Clearside Biomedical, Filed by: WHITMORE BRADFORD T
Low
Report
Form SCHEDULE 13G/A Clearside Biomedical, Filed by: WHITMORE BRADFORD T
2/24
05:53 pm
clsd
Form 4 Clearside Biomedical, For: Feb 24 Filed by: Thorp Clay
Medium
Report
Form 4 Clearside Biomedical, For: Feb 24 Filed by: Thorp Clay
2/21
04:30 pm
clsd
Form SCHEDULE 13D/A Clearside Biomedical, Filed by: Hatteras Venture Advisors IV SBIC, LLC
Medium
Report
Form SCHEDULE 13D/A Clearside Biomedical, Filed by: Hatteras Venture Advisors IV SBIC, LLC
2/13
04:05 pm
clsd
Form 8-K Clearside Biomedical, For: Feb 07
Medium
Report
Form 8-K Clearside Biomedical, For: Feb 07
1/10
04:31 pm
clsd
Form 4 Clearside Biomedical, For: Jan 08 Filed by: Deignan Charles A.
Medium
Report
Form 4 Clearside Biomedical, For: Jan 08 Filed by: Deignan Charles A.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/6
Clearside Biomedical to Present at the 38th Annual J.P. Morgan Healthcare Conference
29.2%
8/7 Q2/2019 6/30/2019 EPS -0.150 ZacksConsensus -0.370 ActVsEst 0.220 - Beat 28.0%
10/22 Clearside Biomedical Inc (NASDAQ: CLSD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $1.00 price target on the stock. 19.0%
9/3 Clearside Biomedical to Present at the Janney Montgomery Scott Healthcare Conference 16.0%
11/26 Form 4 Clearside Biomedical, For: Nov 22 Filed by: Thorp Clay 12.5%
4/8 Clearside Biomedical to Present at the Needham Virtual Healthcare Conference 11.7%
10/3 Clearside Biomedical Announces Multiple Presentations to be Given at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting 9.2%
1/27 Clearside Biomedical Inc (NASDAQ: CLSD) had its price target raised by analysts at Wedbush from $3.00 to $5.00. They now have an "outperform" rating on the stock. 8.5%
3/20 Clearside Biomedical Inc (NASDAQ: CLSD) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. 7.9%
10/21 Clearside Biomedical Inc (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Wedbush. They now have a $3.00 price target on the stock. 7.3%
8/7 Q2/2019 6/30/2019 EPS -0.150 ZacksConsensus -0.370 ActVsEst 0.220 - Beat 28.0%
10/22 Clearside Biomedical Inc (NASDAQ: CLSD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $1.00 price target on the stock. 19.0%
9/3 Clearside Biomedical to Present at the Janney Montgomery Scott Healthcare Conference 16.0%
11/26 Form 4 Clearside Biomedical, For: Nov 22 Filed by: Thorp Clay 12.5%
4/8 Clearside Biomedical to Present at the Needham Virtual Healthcare Conference 11.7%
10/3 Clearside Biomedical Announces Multiple Presentations to be Given at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting 9.2%
1/27 Clearside Biomedical Inc (NASDAQ: CLSD) had its price target raised by analysts at Wedbush from $3.00 to $5.00. They now have an "outperform" rating on the stock. 8.5%
3/20 Clearside Biomedical Inc (NASDAQ: CLSD) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. 7.9%
10/21 Clearside Biomedical Inc (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Wedbush. They now have a $3.00 price target on the stock. 7.3%
TOP News Decliners
8/22
Form 8-K Clearside Biomedical, For: Aug 22
-40.1%
3/11 Form 8-K Clearside Biomedical, For: Mar 11 -36.0%
3/13 Form 424B5 Clearside Biomedical, -29.5%
4/28 Form 8-K Clearside Biomedical, For: Apr 27 -17.4%
2/27 Clearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020 -14.3%
8/26 Clearside Biomedical Inc (NASDAQ: CLSD) was given a new $1.00 price target on by analysts at Laidlaw. They now have a "hold" rating on the stock. -10.6%
8/22 Clearside Biomedical Inc (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $3.00 price target on the stock, down previously from $4.00. -9.6%
9/4 Form 8-K Clearside Biomedical, For: Aug 29 -9.4%
6/4 Form 4 Clearside Biomedical, For: May 31 Filed by: Raymond Brion S. -8.8%
3/16 Form 8-K Clearside Biomedical, For: Mar 11 -8.8%
3/11 Form 8-K Clearside Biomedical, For: Mar 11 -36.0%
3/13 Form 424B5 Clearside Biomedical, -29.5%
4/28 Form 8-K Clearside Biomedical, For: Apr 27 -17.4%
2/27 Clearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020 -14.3%
8/26 Clearside Biomedical Inc (NASDAQ: CLSD) was given a new $1.00 price target on by analysts at Laidlaw. They now have a "hold" rating on the stock. -10.6%
8/22 Clearside Biomedical Inc (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $3.00 price target on the stock, down previously from $4.00. -9.6%
9/4 Form 8-K Clearside Biomedical, For: Aug 29 -9.4%
6/4 Form 4 Clearside Biomedical, For: May 31 Filed by: Raymond Brion S. -8.8%
3/16 Form 8-K Clearside Biomedical, For: Mar 11 -8.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: